Cited by 3,559Angiogenesis and VEGF in CancerCancer Cells and MetastasisMathematical Biology Tumor Growth

The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.

Tumorigenesis and the angiogenic switch

Bergers, Gabriele, Benjamin, Laura E.·2003·Nature reviews. Cancer

Open this paper in CoChat — free account

Abstract

It has become evident that we cannot understand tumour growth without considering components of the stromal microenvironment, such as the vasculature. At the same time, the tumour phenotype determines the nature of the tumour vasculature. Much research is now devoted to determining the impact of angiogenesis on tumour development and progression, and the reciprocal influences of tumour products on the microvasculature. A more detailed understanding of the complex parameters that govern the interactions between the tumour and vascular compartments will help to improve anti-angiogenic strategies-- not only for cancer treatment, but also for preventing recurrence.

Integrity signals

Registry

Crossref · 10.1038/nrc1093

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis
Watnick, R. S., Cheng, Y.-N., Rangarajan, A., Ince, T. A., & Weinberg, R. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00030-8 · Cited by 318
Retracted
The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., de Vries-Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,704
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,235
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699

Flagged first, then by citations

Show all 110 references

Research works printed but not linked: 2

Folkman, J. in Cancer Medicine (Holland, M.D. et al.) 2546 (BC Decker, Hamilton, Ontario, 2000).
Sternlicht, M. D. et al. Matrix proteinases as emerging targets in anticancer therapy: status and prospects. ETT 4, 609–633 (2000).

Sorted by citations

Items 701–800 of 1,010

Cancer-associated fibroblasts in digestive tumors
Huang, L., Xu, A., Liu, S., Liu, W., & Li, T.-J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17804 · Cited by 77
Emerging roles of hypoxia‐inducible factors and reactive oxygen species in cancer and pluripotent stem cells
Saito, S., Lin, Y., Tsai, M., Lin, C., Murayama, Y., Sato, R., & Yokoyama, K. K. (2015) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2015.03.002 · Cited by 76
FITC-Conjugated Cyclic RGD Peptides as Fluorescent Probes for Staining Integrin αvβ3/αvβ5 in Tumor Tissues
Zheng, Y., Ji, S., Czerwiński, A. A., Valenzuela, F., Pennington, M. W., & Liu, S. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500452y · Cited by 76
Molecular Mechanisms of Resistance to Tumour Anti-Angiogenic Strategies
Grépin, R., & Pagès, G. (2010) · Journal of Oncology · doi:10.1155/2010/835680 · Cited by 76
Brain-derived neurotrophic factor increases vascular endothelial growth factor expression and enhances angiogenesis in human chondrosarcoma cells
Lin, C., Hung, S., Chen, H., Tsou, H., Fong, Y., Wang, S., & Tang, C. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.008 · Cited by 75
Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia
Natsuizaka, M., Ozasa, M., Darmanin, S., Miyamoto, M., Kondo, S., Kamada, S., Shindoh, M., Higashino, F., Suhara, W., Koide, H., et al. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.06.013 · Cited by 74
Angiopoietin-2 Serum Levels Are Elevated in Patients With Liver Cirrhosis and Hepatocellular Carcinoma
Scholz, A., Rehm, V. A., Rieke, S., Derkow, K., Schulz, P. M., Neumann, K., Koch, I., Pascu, M., Wiedenmann, B., Berg, T., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01377.x · Cited by 74
Proangiogenic role of neutrophil-like inflammatory heterophils during neovascularization induced by growth factors and human tumor cells
Zijlstra, A., Seandel, M., Kupriyanova, T. A., Partridge, J. J., Madsen, M. A., Hahn-Dantona, E. A., Quigley, J. P., & Deryugina, E. I. (2005) · Blood · doi:10.1182/blood-2005-04-1458 · Cited by 76
Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment
Lee, E., Pandey, N. B., & Popel, A. S. (2015) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2015.2 · Cited by 75
Progranulin promotes colorectal cancer proliferation and angiogenesis through TNFR2/Akt and ERK signaling pathways.
Yang, D., Wang, L.-L., Dong, T., Shen, Y., Guo, X.-S., Liu, C., Liu, J., Zhang, P., Li, J., & Sun, Y.-P. (2015) · Europe PMC (PubMed Central) · Cited by 74
Importance of the Microbiota Inhibitory Mechanism on the Warburg Effect in Colorectal Cancer Cells
Eslami, M., Sadrifar, S., Karbalaei, M., Keikha, M., Kobyliak, N. M., & Yousefi, B. (2019) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-019-00329-3 · Cited by 76
“Therefore, antiangiogenesis therapy has been suggested as an attractive therapeutic pathway for anticancer therapies [34].”
Background
The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors
Une, N., Takano-Kasuya, M., Kitamura, N., Ohta, M., Inose, T., Kato, C., Nishimura, R., Tada, H., Miyagi, S., Ishida, T., et al. (2021) · Medical Oncology · doi:10.1007/s12032-021-01503-z · Cited by 77
“Tumor cells release angiogenic factors such as vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and fibroblast growth factor (FGF), which act on nearby blood vessels to cause tumor angiogenesis [3, 4].”
Background
Modulating Angiogenesis by Proteomimetics of Vascular Endothelial Growth Factor
Abdulkadir, S., Li, C., Jiang, W., Zhao, X., Sang, P., Wei, L., Hu, Y., Li, Q., & Cai, J. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c09571 · Cited by 75
In vitro models of tumor vessels and matrix: Engineering approaches to investigate transport limitations and drug delivery in cancer
Seo, B. R., DelNero, P. F., & Fischbach, C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.011 · Cited by 75
VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix
Soufla, G., Sifakis, S., Baritaki, S., Zafiropoulos, A., Koumantakis, E. E., & Spandidos, D. A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.08.021 · Cited by 74
Synthesis and Biological Evaluation of Polysulfated Oligosaccharide Glycosides as Inhibitors of Angiogenesis and Tumor Growth
Johnstone, K. D., Karoli, T., Liu, L., Dredge, K. S., Copeman, E., Li, C. P., Davis, K., Hammond, E., Bytheway, I., Kostewicz, E. S., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901449m · Cited by 74
The Tumor Microenvironment: Key to Early Detection
Ariztia, E. V., Lee, C. J., Gogoi, R. P., & Fishman, D. A. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360600778836 · Cited by 71
VEGFA activates an epigenetic pathway upregulating ovarian cancer‐initiating cells
Jang, K., Kim, M., Gilbert, C. A., Simpkins, F. A., Ince, T. A., & Slingerland, J. M. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201606840 · Cited by 75
Involvement of Membrane-Type Matrix Metalloproteinases (MT-MMPs) in Capillary Tube Formation by Human Endometrial Microvascular Endothelial Cells: Role of MT3-MMP
Plaisier, M., Kapiteijn, K., Koolwijk, P., Fijten, C., Hanemaaijer, R., Grimbergen, J. M., Mulder-Stapel, A. A., Quax, P. H. A., Helmerhorst, F. M., & van Hinsbergh, V. W. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0860 · Cited by 74
Isolation and Characterization of “Terrein” an Antimicrobial and Antitumor Compound from Endophytic Fungus Aspergillus terreus (JAS-2) Associated from Achyranthus aspera Varanasi, India
Goutam, J., Sharma, G., Tiwari, V. K., Mishra, A., Kharwar, R. N., Ramaraj, V., & Koch, B. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01334 · Cited by 74
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer
Kim, G. H., Won, J. E., Byeon, Y., Kim, M. G., Wi, T. I., Lee, J. M., Park, Y., Lee, J., Kang, T. H., Jung, I. D., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1480672 · Cited by 73
Cancer Anti-angiogenic Therapy
Shimizu, K., & Oku, N. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.599 · Cited by 74
Synergistic effects of cell-penetrating peptide Tat and fusogenic peptide HA2-enhanced cellular internalization and gene transduction of organosilica nanoparticles
Ye, S., Tian, M.-M., Wang, T., Ren, L., Wang, D., Shen, L., & Shang, T. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.10.003 · Cited by 74
The VEGF/Rho GTPase signalling pathway: A promising target for anti-angiogenic/anti-invasion therapy
van der Meel, R., Symons, M. H., Kudernatsch, R., Kok, R. J., Schiffelers, R. M., Storm, G., Gallagher, W. M., & Byrne, A. T. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.01.005 · Cited by 73
An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogenesis, apoptosis and metastasis
Lee, H., Lee, E.-O., Rhee, Y., Ahn, K. S., Li, G.-X., Jiang, C., Lü, J., & Kim, S. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl104 · Cited by 73
Antiangiogenic Effects of Coumarins against Cancer: From Chemistry to Medicine
Majnooni, M. B., Fakhri, S., Smeriglio, A., Trombetta, D., Croley, C. R., Bhattacharyya, P., Sobarzo‐Sánchez, E., Farzaei, M. H., & Bishayee, A. (2019) · Molecules · doi:10.3390/molecules24234278 · Cited by 79
Recapitulating the vasculature using ORGAN-ON-CHIP technology
Pollet, A. M. A. O., & den Toonder, J. M. J. (2020) · Bioengineering · doi:10.3390/bioengineering7010017 · Cited by 73
Adverse Events Associated with Anti-EGFR Therapies for the Treatment of Metastatic Colorectal Cancer
Fakih, M., & Vincent, M. D. (2010) · Current Oncology · doi:10.3747/co.v17is1.615 · Cited by 152
Targeting macrophages: a novel treatment strategy in solid tumors
Liu, M., Liu, L., Song, Y., Li, W., & Xu, L. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03813-w · Cited by 73
Milestones in tumor vascularization and its therapeutic targeting
Palma, M. D., & Hanahan, D. (2024) · Nature Cancer · doi:10.1038/s43018-024-00780-7 · Cited by 79
“The induction of tumor angiogenesis (the ‘angiogenic switch’) was found to represent a discrete and requisite step in the multistage development of certain tumor types 19–21 , leading to its incorporation as a qualitatively distinct hallmark of cancer 22 .”
Influential
Heterogeneity of tumor endothelial cells
Hida, K., Ohga, N., Akiyama, K., Maishi, N., & Hida, Y. (2013) · Cancer Science · doi:10.1111/cas.12251 · Cited by 72
The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy
Kidoya, H., Kunii, N., Naito, H., Muramatsu, F., Okamoto, Y., Nakayama, T., & Takakura, N. (2011) · Oncogene · doi:10.1038/onc.2011.489 · Cited by 72
Fibroblast growth factor‐2‐induced host stroma reaction during initial tumor growth promotes progression of mouse melanoma via vascular endothelial growth factor A‐dependent neovascularization
Tsunoda, S., Nakamura, T., Sakurai, H., & Saiki, I. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00432.x · Cited by 72
Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors
van Eekelen, M., Sasportas, L. S., Kasmieh, R., Yip, S. S. F., Figueiredo, J.-L., Louis, D. N., Weissleder, R., & Shah, K. (2010) · Oncogene · doi:10.1038/onc.2010.75 · Cited by 72
Incidental Neuroendocrine Tumors of the Pancreas: MDCT Findings and Features of Malignancy
Gallotti, A., Johnston, R. P., Bonaffini, P. A., Ingkakul, T., Deshpande, V., Castillo, C. F. F.-D., & Sahani, D. V. (2013) · American Journal of Roentgenology · doi:10.2214/ajr.11.8037 · Cited by 71
Crosstalk between long noncoding RNA and microRNA in Cancer
Bhattacharjee, R., Prabhakar, N., Kumar, L., Bhattacharjee, A., Kar, S., Malik, S., Kumar, D., Ruokolainen, J., Negi, A., Jha, N. K., et al. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00806-9 · Cited by 72
HIF-1α and Cancer Therapy
Koh, M. Y., Spivak-Kroizman, T. R., & Powis, G. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-78281-0_3 · Cited by 70
Angiogenesis in cancer
Poettler, M., & Prager, G. W. (2011) · Hämostaseologie · doi:10.5482/ha-1163 · Cited by 73
Integrin modulators: a patent review
Kapp, T. G., Rechenmacher, F., Sobahi, T. R., & Kessler, H. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.818133 · Cited by 71
The Dickkopf‐homolog 3 is expressed in tumor endothelial cells and supports capillary formation
Untergasser, G., Steurer, M., Zimmermann, M., Hermann, M., Kern, J., Amberger, A., Gastl, G. A., & Gunsilius, E. (2007) · International Journal of Cancer · doi:10.1002/ijc.23255 · Cited by 69
Human Endocrine Gland-Derived Vascular Endothelial Growth Factor: Expression Early in Development and in Leydig Cell Tumors Suggests Roles in Normal and Pathological Testis Angiogenesis
Samson, M., Peale, F. V., Jr., Frantz, G. D., Rioux-Leclercq, N. C., Meyts, E. R., & Ferrara, N. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032024 · Cited by 71
Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation
Shubbar, E., Vegfors, J., Carlström, M., Petersson, S., & Enerbäck, C. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1920-5 · Cited by 71
VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer
Chen, J., Sun, X., Shao, R., Xu, Y., Gao, J., & Liang, W. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s142739 · Cited by 71
Increased complexity in carcinomas: Analyzing and modeling the interaction of human cancer cells with their microenvironment
Stadler, M., Walter, S., Walzl, A., Kramer, N., Unger, C., Scherzer, M., Unterleuthner, D., Hengstschläger, M., Krupitza, G., & Dolznig, H. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.08.007 · Cited by 73
Role of angiogenesis in pancreatic cancer biology and therapy
Zhang, Z., Ji, S., Zhang, B., Liu, J., Qin, Y., Xu, J., & Yu, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.136 · Cited by 72
The pathophysiology of chronic subdural hematoma revisited: emphasis on aging processes as key factor
Weigel, R., Schilling, L., & Krauss, J. K. (2022) · GeroScience · doi:10.1007/s11357-022-00570-y · Cited by 81
“Moreover, Hua and colleagues correlated the concentration of VEGF and matrix metalloproteinase (MMP) 2 and 9 [53] which are important proangiogenic factors that trigger an angiogenic switch in an otherwise quiescent vascular bed [54, 55].”
Background
Plants as a Source of Anticancer Agents: From Bench to Bedside
Talib, W. H., Daoud, S., Mahmod, A. I., Hamed, R. A., Awajan, D., Abuarab, S. F., Odeh, L. H., Khater, S. H., & Kury, L. T. A. (2022) · Molecules · doi:10.3390/molecules27154818 · Cited by 75
The Invadopodia Scaffold Protein Tks5 Is Required for the Growth of Human Breast Cancer Cells In Vitro and In Vivo
Blouw, B., Patel, M., Iizuka, S., Abdullah, C., You, W. K., Huang, X., Li, J., Díaz, B., Stallcup, W. B., & Courtneidge, S. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121003 · Cited by 70
The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies
Fokas, E., McKenna, W. G., & Muschel, R. J. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9394-4 · Cited by 70
Cancer models, genomic instability and somatic cellular Darwinian evolution
Little, M. P. (2010) · Biology Direct · doi:10.1186/1745-6150-5-19 · Cited by 69
AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patients
Langlois, B., Saupe, F., Rupp, T., Arnold, C., van der Heyden, M., Orend, G., & Hussenet, T. (2014) · Oncotarget · doi:10.18632/oncotarget.2470 · Cited by 76
Angiogenic Profile of Soft Tissue Sarcomas Based on Analysis of Circulating Factors and Microarray Gene Expression
Yoon, S. S., Segal, N. H., Park, P. J., Detwiller, K. Y., Fernando, N. T., Ryeom, S. W., Brennan, M. F., & Singer, S. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2006.01.023 · Cited by 70
TWEAK/Fn14 signaling in tumors
Hu, G., Zeng, W., & Xia, Y. (2017) · Tumor Biology · doi:10.1177/1010428317714624 · Cited by 70
The Role of Brain Vasculature in Glioblastoma
KANE, J. R. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1561-y · Cited by 72
Chorioallantoic Membrane Assay as Model for Angiogenesis in Tissue Engineering: Focus on Stem Cells
Merckx, G., Tay, H., Monaco, M. L., van Zandvoort, M. A. M. J., Spiegelaere, W. D., Lambrichts, I., & Bronckaers, A. (2020) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2020.0048 · Cited by 70
Autocrine signaling in carcinoma: VEGF and the α6β4 integrin
Mercurio, A. M., Bachelder, R. E., Bates, R. C., & Chung, J. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.09.016 · Cited by 72
ARF tumor suppression in the nucleolus
Maggi, L. B., Winkeler, C. L., Miceli, A. P., Apicelli, A. J., Brady, S. N., Kuchenreuther, M., & Weber, J. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.01.016 · Cited by 73
“VEGFA is a key mediator of angiogenesis because VEGFA stimulates the growth of new blood vessels from adjacent microvessels [148].”
Background
Therapeutic Targeting of the Colorectal Tumor Stroma
Fridman, W. H., Miller, I. S., Sautès‐Fridman, C., & Byrne, A. T. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.09.045 · Cited by 72
Dynamics of tumor growth and combination of anti-angiogenic and cytotoxic therapies
Kohandel, M., Mehran Kardar, A., Milosevic, M., & Sivaloganathan, S. (2007) · Physics in Medicine and Biology · doi:10.1088/0031-9155/52/13/001 · Cited by 74
Molecular Pathways in Renal Cell Carcinoma—Rationale for Targeted Treatment
KIM, W., & KAELINJR, W. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.06.001 · Cited by 73
FKBPL and Peptide Derivatives: Novel Biological Agents That Inhibit Angiogenesis by a CD44-Dependent Mechanism
Valentine, A., O’Rourke, M., Yakkundi, A., Worthington, J., Hookham, M. B., Bicknell, R., McCarthy, H. O., McClelland, K., McCallum, L. M. R., Dyer, H., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2241 · Cited by 68
Dose‐Dependent Therapeutic Distinction between Active and Passive Targeting Revealed Using Transferrin‐Coated PGMA Nanoparticles
Singh, R., Nörret, M., House, M. J., Galabura, Y., Bradshaw, M., Ho, D., Woodward, R. C., Pierre, T. G. S., Luzinov, I. A., Smith, N. M., et al. (2015) · Small · doi:10.1002/smll.201502730 · Cited by 71
Inhibition of VEGF-Induced VEGFR-2 Activation and HUVEC Migration by Melatonin and Other Bioactive Indolic Compounds
Cerezo, A. B., Ortega, R. H., Álvarez‐Fernández, M. A., Troncoso, A. M., & García-Parrilla, M. C. (2017) · Nutrients · doi:10.3390/nu9030249 · Cited by 68
Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis
Mazzone, M., & Bergers, G. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114721 · Cited by 70
Metastasis and Angiogenesis
Kirsch, M., Schackert, G., & Black, P. M. (2004) · Cancer treatment and research · doi:10.1007/978-1-4419-8871-3_17 · Cited by 70
CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms
D’Onofrio, M., Ciaravino, V., Cardobi, N., Robertis, R. D., Cingarlini, S., Landoni, L., Capelli, P., Bassi, C., & Scarpa, A. (2019) · Scientific Reports · doi:10.1038/s41598-018-38459-6 · Cited by 68
Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology
Jan, N., Sofi, S., Qayoom, H., Shabir, A., Haq, B. U., Macha, M. A., Almilaibary, A., & Mir, M. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24670 · Cited by 68
“Both during the onset of cancer formation and throughout the remission stage following the completion of anticancer therapy, tumors might recommence their progression from persisting residual illness [93].”
Background
Recent developments in dynamic contrast-enhanced ultrasound imaging of tumor angiogenesis
Saini, R., & Hoyt, K. (2014) · Imaging in Medicine · doi:10.2217/iim.13.74 · Cited by 68
Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells
Pezzolo, A., Parodi, F., Marimpietri, D., Raffaghello, L., Cocco, C., Pistorio, A., Mosconi, M., Gambini, C., Cilli, M., Deaglio, S., et al. (2011) · Cell Research · doi:10.1038/cr.2011.38 · Cited by 68
Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial–mesenchymal transition and promotes tumor growth and angiogenesis
Oh, E., Kim, J. Y., Cho, Y., An, H., Lee, N., Jo, H., Ban, C., & Seo, J. H. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.03.010 · Cited by 68
Synthesis and Evaluation of 64Cu-Labeled Monomeric and Dimeric NGR Peptides for MicroPET Imaging of CD13 Receptor Expression
Chen, K., Ma, W., Li, G., Wang, J., Yang, W., Yap, L.-P., Hughes, L. D., Park, R. J.-H., & Conti, P. S. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3005676 · Cited by 68
KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth
Nakamura, K., Yamamoto, A., Kamishohara, M., Takahashi, K., Taguchi, E., Miura, T., Kubo, K., Shibuya, M., & Isoe, T. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1639.3.12 · Cited by 68
Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets
Talib, W. H., Alsayed, A. R., Farhan, F., & Kury, L. T. A. (2020) · Molecules · doi:10.3390/molecules25184282 · Cited by 74
Engineering Chameleon Prodrug Nanovesicles to Increase Antigen Presentation and Inhibit PD‐L1 Expression for Circumventing Immune Resistance of Cancer
Zhou, F., Gao, J., Tang, Y., Zou, Z., Jiao, S., Zhou, Z., Xu, H., Xu, Z. P., Yu, H., & Xu, Z. (2021) · Advanced Materials · doi:10.1002/adma.202102668 · Cited by 67
The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment
Fridman, E., Ginini, L., & Gil, Z. (2022) · Cells · doi:10.3390/cells11091433 · Cited by 69
MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment
Bartolucci, D., Montemurro, L., Raieli, S., Lampis, S., Pession, A., Hrelia, P., & Tonelli, R. (2022) · Cancers · doi:10.3390/cancers14184421 · Cited by 70
Non-invasive assessment of vessel morphology and function in tumors by magnetic resonance imaging
Kiessling, F. M., Jugold, M., Woenne, E. C., & Brix, G. (2007) · European Radiology · doi:10.1007/s00330-006-0566-x · Cited by 67
INGN 201 (Advexin®): adenoviral p53 gene therapy for cancer
Gabrilovich, D. I. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.8.823 · Cited by 68
Recent Advances in Vascular Disrupting Agents in Cancer Therapy
Porcù, E., Bortolozzi, R., Basso, G., & Viola, G. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.104 · Cited by 67
Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression
Yoshiji, H., Kuriyama, S., Noguchi, R., Yoshii, J., Ikenaka, Y., Yanase, K., Namisaki, T., Kitade, M., Yamazaki, M., Masaki, T., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.12.025 · Cited by 67
Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis
Shah, S., & D’Souza, G. G. M. (2025) · Cells · doi:10.3390/cells14100732 · Cited by 83
“This neovascularization represents a rate-limiting step in tumor progression [47].”
Cancer-on-chip models for metastasis: importance of the tumor microenvironment
Jouybar, M., de Winde, C. M., Wolf, K., Friedl, P., Mebius, R. E., & den Toonder, J. M. J. (2024) · Trends in Biotechnology · doi:10.1016/j.tibtech.2023.10.001 · Cited by 66
“Instead of triggering angiogenesis, some tumors co-opt existing vasculature and grow along the vessels [53 – 56], until the demand for nutrients and oxygen becomes too large and angiogenesis starts again [53,55].”
Background
The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55)
Bzyl, J., Palmowski, M., Rix, A., Arns, S., Hyvelin, J.-M., Pochon, S., Ehling, J., Schrading, S., Kiessling, F. M., & Lederle, W. (2012) · European Radiology · doi:10.1007/s00330-012-2594-z · Cited by 66
Decreased miR-200b-3p in cancer cells leads to angiogenesis in HCC by enhancing endothelial ERG expression
Moh-Moh-Aung, A., Fujisawa, M., Ito, S., Katayama, H. G., Ohara, T., Ota, Y., Yoshimura, T., & Matsukawa, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-67425-4 · Cited by 66
Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy
Zhang, Y., Li, Y., Chen, K., Qian, L. M., & Wang, P. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01972-2 · Cited by 65
CXCL8 Signaling in the Tumor Microenvironment
Asokan, S., & Bandapalli, O. R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-62658-7_3 · Cited by 66
Folate-Targeted Multifunctional Amino Acid-Chitosan Nanoparticles for Improved Cancer Therapy
Gaspar, V. M., Costa, E. C., Queiroz, J. A., Pichon, C., de Sousa, F. P., & Correia, I. J. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1486-0 · Cited by 66
Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas
Niveiro, M., Aranda, I., Peiró, G., Alenda, C., & Pico, A. M. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.07.015 · Cited by 66
Metabotropic Glutamate Receptor-1 as a Novel Target for the Antiangiogenic Treatment of Breast Cancer
Speyer, C. L., Hachem, A. H., Assi, A. A., Johnson, J. S., DeVries, J. A., & Gorski, D. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088830 · Cited by 66
Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas
Fjällskog, M.-L., Hessman, O., Eriksson, B. K., & Janson, E. T. (2006) · Acta Oncologica · doi:10.1080/02841860601048388 · Cited by 66
Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies
Frumovitz, M., & Sood, A. K. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.10.062 · Cited by 67
MicroRNA-mediated regulation of the angiogenic switch
Anand, S., & Cheresh, D. A. (2011) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328345a180 · Cited by 67
Imaging Tumor Vascularization for Detection and Diagnosis of Breast Cancer
Heijblom, M., Klaase, J. M., van den Engh, F. M., van Leeuwen, T. G. J. M., Steenbergen, W., & Manohar, S. (2011) · Technology in Cancer Research & Treatment · doi:10.7785/tcrt.2012.500227 · Cited by 66
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) and proteolytic processing by a disintegrin and metalloproteinases (ADAM): A regulator of several pathways
Taylor, S. R., Markesbery, M. G., & Harding, P. A. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.03.004 · Cited by 74
ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside
Zhou, J., Goh, B.-C., Albert, D. H., & Chen, C.-S. (2009) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-2-33 · Cited by 65
Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients
Igreja, C., Courinha, M., Cachaço, A. S., Pereira, T., Cabeçadas, J., da Silva, M. G., & Dias, S. (2007) · Haematologica · doi:10.3324/haematol.10723 · Cited by 66
c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α
Chen, C. Y., Cai, S., Wang, G., Cao, X., Yang, X., Luo, X., Feng, Y., & Hu, J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.006 · Cited by 67
Role of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, and Vascular Endothelial Growth Factor in the Development of Chronic Subdural Hematoma
Hua, C., Zhao, G., Feng, Y., Yuan, H., Song, H., & Bie, L. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2014.3724 · Cited by 70
Advances in antitumor polysaccharides fromphellinussensu lato: Production, isolation, structure, antitumor activity, and mechanisms
Yan, J., Pei, J.-J., Ma, H., Wang, Z.-B., & Liu, Y. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.984802 · Cited by 66
“In cancers, new vessel formation contributes to the progressive growth and metastasis of solid tumors (Bergers and Benjamin, 2003).”
Background
Exosomes from Plasmodium-infected hosts inhibit tumor angiogenesis in a murine Lewis lung cancer model
Yang, Y., Liu, Q., Lü, J., Adah, D., Yu, S., Zhao, S., Yao, Y., Li, Q., Li, Q., & Chen, X. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.52 · Cited by 67

Authors: Bergers, G., & Benjamin, L. E.
Affiliations: University of California, San Francisco (US)
Beth Israel Deaconess Medical Center (US)
Corresponding author: Bergers, Gabriele
ORCID: Bergers, Gabriele
Venue: Nature reviews. Cancer
Publisher: Springer Science and Business Media LLC
Published: 2003-06
Volume: 3
Issue: 6
Pages: 401-410
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc1093
OpenAlex: W2804842145
Cited by: 3,559
References: 110
Citations by year: 2026: 53 · 2025: 79 · 2024: 123 · 2023: 122 · 2022: 142 · 2021: 160 · 2020: 149 · 2019: 159 · 2018: 162 · 2017: 176 · 2016: 148 · 2015: 176 · 2014: 232 · 2013: 223 · 2012: 198
FWCI: 9.49
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
Keywords: carcinogenesis, angiogenic switch, tumor angiogenesis, tumor vasculature, tumor microenvironment, tumor-stroma interactions, tumor progression, anti-angiogenic therapy, tumor recurrence
MeSH terms: Animals, Humans, Neoplasms, Neovascularization, Pathologic, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumorigenesis and the angiogenic switch

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks